Brett Saunders

Who Will Pay for Prescription #Drugs in 2032: Four Takeaways from the New Government Forecasts DCI's analysis of the latest Centers for Medicare & Medicaid Services projections ==> https://drugch.nl/3xX6QQM

72

12 Comments

Many innovative ideas can become obscured when communicated, which was a significant challenge for Patient Blood Management #PBM as it was introduced to benefit those suffering from #anemia, in hopes of enabling surgery without the use of donated blood upon leaving the ER (Emergency Room). The PBM educational approach supports bloodless surgical procedures. To reduce this obscurity, we are simplifying the message and increasing awareness, benefiting #researchers, manufacturers, and healthcare practitioners. Most importantly, we are enhancing the patient experience and raising public awareness. We are confident that many global organizations, healthcare providers, and blood management surgical equipment manufacturers will support our efforts as we continue to be pioneers in building a bridge of engagement for public access, which will benefit this field of medicine. Remember our medical icons, just in case one day you need direction to the OR. #Bloodlines #BBTS #Blood #SABM

5

HTA evaluates the value of medical technologies, but too often, patient perspectives are left out of the process. Including patient input ensures decisions reflect their needs, leading to better outcomes and greater health equity. Explore how Patient-Centered HTA is shaping a more inclusive healthcare system in this blog by Xanthia Lam, MPH candidate at Columbia University and Center Patient Engagement Intern: https://ow.ly/oTZe50UBybT #HealthEquity #PatientEngagement #HTA #HealthcareInnovation

4

Worth reading: Avalere explains how a #340B rebate model could resolve duplicate discounts with #IRA MFPs. Good overview of complexities and industry challenges. But will #hospitals allow problem to be solved? ==> https://drugch.nl/3ZeG4il

138

3 Comments

Podcast advertising is changing the game for clinical trial recruitment! 🚀 Check out this article to see how it stacks up against traditional media. 🎧 #clinicaltrials #podcastadvertising

5

How do you think about data quantity vs. data quality when it comes to RWD? COTA's Sandy Leonard recently sat down with Karla Feghali, MBA of Deloitte and shared how the quantity-versus-quality question has evolved in clinical research. "When RWE was emerging, companies were focused on accessing as much data as they could. The idea was that if you had the entire haystack, you were bound to find the couple of needles that were important for your study. For years, data buyers and researchers were focused almost entirely on quantity. I think the industry has evolved significantly as companies have gained more exposure to different types of data and now have technologies that can help improve the quality of the data. A company no longer needs to start with a large quantity in order to get to quality. Targeted data from the right 300 patients might be more useful than a cohort of 10 million patients." https://lnkd.in/dX8euKAF #rwd #realworlddata #oncologyresearch

13

There are endless barriers for patients to initiate and adhere to their specialty medications, from cost to insurance approvals and beyond. In our recent #blog, we break down some of these barriers and discuss the ways in which innovative technologies can help patients and providers accelerate enrollment and achieve better outcomes. ⚡ Check it out! #specialtypharmacy #digitalhealth #medaccess

28

New Podcast Series Alert: Beyond the Data Podcast This week, I’m thrilled to introduce Geoffrey Banks, Ph.D., a serial entrepreneur, industry leader, and author of the eye-opening new book, The Growth Mindset Illusions: Achieving Success as a Steady-State Entrepreneur. Geoff's story is one of resilience, strategy, and raw honesty. As the Founder & CEO of Nuventra Pharma Sciences, a consulting powerhouse specializing in pharmacokinetics, pharmacodynamics, modeling, simulations, and clinical pharmacology, Geoff achieved remarkable growth year-over-year. But his journey didn’t stop there. Geoff also co-founded First Order Pharmaceuticals, in parallel. In this series of short episodes, Geoff takes us on a behind-the-scenes journey—sharing not just the wins, but the emotions, lessons, and truths that come with building and transitioning out of successful businesses. Whether you're an entrepreneur, a leader, or someone looking for authentic insights into business and personal growth, this series is for you. Geoff’s book isn’t just about being an entrepreneur—it’s about navigating the myths and realities of success. And this discussion? It’s not polished, rehearsed, or sugarcoated. It’s raw. It’s real. It’s Beyond the Data. Tune in as we unpack: - The truth behind steady-state entrepreneurship - How to manage growth and purpose in tandem - What life feels like after selling a business - Tips from Geoff's experiences Episode drops this week! Don’t miss this chance to gain wisdom from one of the industry's best. You can find his book on Amazon and for me, the timing couldn't have been any better to have this opportunity to sit down with him as I embark on my new endeavors. We hope you enjoy! #BeyondTheDataPodcast #Entrepreneurship #GrowthMindset #ClinicalResearch #DrugDevelopment #ClinicalPharmacology #Innovation #Leadership

37

Thoughtful planning in the establishment of a commercial data strategy prior to brand launch can help to frame the approach to patient-centricity. Data warehouses are a lot of work to rebuild, the tips in this Beghou Consulting article help to provide four keys to inform that planning so that patients stay at the center of focus. #data #pharma #biotech #patient-centered

15

Marketers today need to improve campaign performance quickly, optimize frequently, and be confident they have the right analysis to drive the right decisions. Too often, though, we hear from marketers they aren’t getting analysis that is actionable or that can even answer their critical business questions. My amazing colleagues, Rachel Cunningham, Kit Burkus, and Sarah Brown, are ready to spill the tea on measurement, sharing the green (and red) flags to look for and helping marketers get the most out of every marketing dollar. Register today: https://lnkd.in/eX8wfXpt

18

For over three decades, major Patient Blood Management (#PBM) associations, #pharmaceutical companies, #manufacturers, and #bloodless surgery hospital programs have heavily marketed to doctors, believing their buy-in was essential. However, this approach may have overlooked broader areas of interest. In the past five years, we've shifted our focus to cultivating public interest in Patient Blood Management, becoming pioneers in this approach. This has proven immensely valuable, creating an engaged infrastructure between healthcare providers and patients, enhancing understanding and collaboration in this evolving field of medicine. To address emerging challenges such as patient experience, safety, communication, and language, we're excited to introduce our Collaborative Optimal Outcome Language (COOL) initiative. This program provides support and training for hospitals to adapt to changing trends, paradigm shifts, and the needs of this new healthcare culture. The engagement bridge we've constructed is now open for all stakeholders in PBM to have open public access as we work together in collaboration, exchange, and education of a new language in life.

19

4 Comments

Join myself and Elizabeth Wagner this morning to learn more about designing better clinical trials! IQVIA Technologies

2

While this topic has been well-researched and the contributions of its authors are highly valued, the question remains: Is there more we can do to better expose this beneficial protocol of Patient Blood Management #PBM to the public? Healthcare stakeholders in patient blood management need to recognize that yesterday's target market allowed more leeway in using traditional marketing strategies to raise patient awareness. Today’s consumer-oriented patients are part of a digital culture that has little patience for complexity, unapproachable branding, or visuals that fail to resonate with the target audience. Our goal at Red Bloodless Medicine and Surgery is to create branding and foster partnerships that will strengthen this category and broaden awareness. Let's partner before it's too late, and we miss the opportunity to connect with another evolving culture.

9

Patient Blood Management #pbm is leading a global revolution in anemia care, uniting a diverse network of organizations, medical centers, and advocates. As the premier strategy for addressing iron deficiency, PBM has become essential in the fight against anemia. The challenge is demonstrating a collective commitment to this cause. Success in this battle relies not on individual voices but on presenting a unified front. Just as wars are won by clearly recognized and united armies, not by isolated teams, success depends on showing that everyone involved is fighting the same war. To this end, the #Anemia Emblem is introduced—a symbol of the shared mission and a clear sign of unity in this effort. This emblem represents true global innovation and growth, serving as a powerful, global identifier that showcases to patients, healthcare providers, and the public the unified dedication to managing anemia through PBM. Each time the Anemia Emblem is seen, it reinforces the joint effort and underscores the importance of PBM in improving anemia care worldwide. Just as the NO BLOOD emblem has long symbolized patients' preferences, the Anemia Emblem will become a recognized mark of collective commitment to battling anemia. By uniting under this emblem, the resolve is strengthened, demonstrating that together, a significant difference is being made. Time is not on our side in this battle. The sooner the recognition, the sooner the momentum will occur in saving the lives of others and managing the use of patients' blood.

3